Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-21-008537

← back to feed
Filed
Apr 12, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 12, 2021 160.74M sh
Cash And Equivalents Q1 2020 · Mar 31, 2020 $24.51K
Cash And Equivalents Q1 2020 · Dec 31, 2019 $14.83K
Current Liabilities Q1 2020 · Mar 31, 2020 $2.78M
Current Liabilities Q1 2020 · Dec 31, 2019 $2.19M
Total Liabilities Q1 2020 · Mar 31, 2020 $3.48M
Total Liabilities Q1 2020 · Dec 31, 2019 $2.88M
Current Assets Q1 2020 · Mar 31, 2020 $644.13K
Current Assets Q1 2020 · Dec 31, 2019 $604.43K
Total Assets Q1 2020 · Mar 31, 2020 $4.56M
Total Assets Q1 2020 · Dec 31, 2019 $4.47M
Capex Q1 2020 · Mar 31, 2019 $729.51K
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$1.21M
Net Income Q1 2020 · Mar 31, 2019 −$1.29M
Operating Income restated Q1 2020 · Mar 31, 2019 −$994.31K
Gross Profit Q1 2020 · Mar 31, 2019 $89.23K
Revenue Q1 2020 · Mar 31, 2019 $720.8K